C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 2,095.00
+141.00 (7.22%)
At close: Nov 13, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 24.08 billion as of November 13, 2026. It is the 37,934th most valuable company in the world and the 2,307th biggest in South Korea. Its market cap has decreased by 52.45% in one year.
Market Cap
24.08B
Enterprise Value
21.32B
Revenue
63.55B
Global Rank
Country Rank
#2,307 South Korea
PE Ratio
14.56
ChartMarket Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 19.05B to 24.08B, an increase of 26.39%. That is a compound annual growth rate of 4.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 24.08B | -53.45% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 468.92% |
| Dec 9, 2021 | 19.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 340.08B |
| DreamCIS | 94.34B |
| HLB bioStep | 70.54B |
| P&K Skin Research Center | 52.28B |
| Kolmar BioTech | 30.66B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 26.34B |
| Curachem | 12.65B |